| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $90K | +500.0% | +2900.0% |
| R&D Expense | $49.4M | +3.1% | +28.5% |
| SG&A Expense | $11.8M | +2.8% | -6.4% |
| Operating Income | -$61.2M | -2.9% | -19.7% |
| Income Tax | $0 | — | — |
| Net Income | -$56.9M | -4.1% | -29.7% |
| EPS (Basic) | -$1.01 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $48.6M | -37.1% | -74.1% |
| Short-term Investments | $256.5M | +18.7% | -18.4% |
| Current Assets | $312.4M | +3.0% | -38.8% |
| Total Assets | $424.0M | -10.5% | -29.8% |
| Current Liabilities | $37.1M | +7.0% | +25.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$137.6M | — | — |
| Capital Expenditures | $606K | — | — |
| Investing Cash Flow | $35.9M | — | — |
| Financing Cash Flow | $978K | — | — |
| Free Cash Flow | -$138.2M | — | — |
| -27.8% |
| EPS (Diluted) | -$1.01 | -3.1% | -27.8% |
| $55.0M |
| +4.3% |
| +7.7% |
| Stockholders' Equity | $369.0M | -12.3% | -33.3% |